NEW YORK, NY - AUGUST 22, 2012 - TCT 2012 (Transcatheter Cardiovascular Therapeutics), the annual scientific symposium of the Cardiovascular Research Foundation will provide significant clinical research updates to technologies and practices in interventional cardiology that will directly affect patient care. The complete agenda for the conference is now available at: http://www.tctconference.com/agenda.html.
At TCT 2012 (October 22-26 in Miami, FL), late breaking data from clinical trials on the next generation of stents, interventional cardiology techniques, and the interactions and effectiveness of new medicines will shed light on the best ways to treat patients.
Several hundred abstracts will also be presented on a variety of interesting topics including studies on the latest valve replacement procedures, the impact of gender on angioplasty and other procedures, and new developments in plaque excision. Additional newsworthy abstracts will focus on comparisons of new stents and trends in identifying which entry points in the body are best for catheter-based procedures.
In addition to the oral and poster abstracts, TCT will feature several late-breaking clinical trials and first report investigations. The topics of those late-breaking studies will be announced in late September.
TCT, the world's premier educational meeting specializing in interventional cardiovascular medicine, gathers leading medical researchers and clinicians from around the world to present and discuss the latest evidence-based research developments.
Members of the media may register for TCT 2012 here: http://www.tctconference.com/press/press-pre-registration-form.html
And to learn more about the conference, visit: http://www.tctconference.com/.
The Cardiovascular Research Foundation (CRF) is an independent, academically focused nonprofit organization dedicated to improving the survival and quality of life for people with cardiovascular disease through research and education. Since its inception in 1991, CRF has played a major role in realizing dramatic improvements in the lives of countless numbers of patients by establishing the safe use of new technologies and therapies in interventional cardiovascular medicine. For more information, visit www.crf.org.
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.